Absence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia

Table 1

Genotype distribution of CCR5 rs333 polymorphism and recurrence risk status analysis in ALL and control groups.

	Genotypes		OR	95% CI	𝑃^∗
	CCR5/CCR5	CCR5/Δ32
Control (80)	73 (91.25%)	7 (8.75%)	0.7	0.21–2.32	0.76
ALL (79)	74 (92.5%)	5 (7.5%)
High risk (50)	47 (94%)	3 (6%)	0.86	0.13–5.48	1.00
Low risk (29)	27 (93.1%)	2 (6.9%)

 *Fisher’s exact test, 𝑃>0.05. OR: odds ratio; CI: confidence interval.